- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01007422
Opioids Titration in Hospice Patients
Opioid Titration In the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part B
RATIONALE: Opioids lessen pain caused by cancer. Titration of opioids in the hospice setting is suboptimal due to numerous barriers. Order sets may help to provide timely and effective medical and pharmaceutical intervention.
PURPOSE: The purpose of this study was to identify barriers to good pain control in the hospice setting and to develop an order set that would safely address these barriers.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Objective 1:
To assess barriers to pain control in the hospice setting.
Using a mixed methods approach, key stakeholders including physicians, nurses, patients and caregivers were queried about pain control in the hospice setting, barriers to pain control and the desirability of an order set to address this issue.
Objective 2:
To develop and conduct pilot testing of an order set designed to improve pain control in the hospice setting.
An opioid titration order sheet based on our previous R0-1 was modified based on the information derived from the interviews and questionnaires completed by the physicians, nurses, patients and caregivers.
A cohort of 20 patients were enrolled on the first phase of the pilot study in order to test the modified pain assessment form and the feasibility administration of the study materials to be completed by the patient and caregiver. Forms are as follows:
- Patient assessment: At baseline, patients provide demographic data and complete the Pain Assessment Form and the Pain Communication Survey. The pain assessment form addresses average pain, worst pain, pain relief, hours in pain, pain-related distress, and barriers to pain control. Patients are asked to rate pain control. Patients also complete the Pain Communication Survey to assess how they communicate with healthcare providers about their pain. After the baseline assessment is completed, patients complete the Pain Assessment form on a daily basis. Pain is also assessed by the research nurse at least 3 times weekly (1 home visit* and 2 telephone interviews). Patients are followed until the time of death.
NOTE: *If a patient is hospitalized or transferred to the inpatient hospice facility, the patient interview will take place there.
- Caregiver assessment: At baseline, caregivers complete a demographic survey, a Pain Assessment Form, the Pain Communication Survey, Caregiver Self-Efficacy in Pain Management Scale (CSEPMS), Caregiver Pain Management Questionnaire (CPMQ), and the Stressful Caregiver Adult Reactions to Experiences of Dying (SCARED). Caregivers are then interviewed by the study nurse using the Pain Assessment Form as a guideline to obtain more detailed information about adequacy of the patient's pain control, side effects of medication, barriers to pain control, and caregiver concerns and burden. Follow-up data from caregivers is obtained through completion of CSEPMS, CPMQ, and SCARED questionnaires and their assessment of patient's pain form at the end of weeks 1, 2, and 3.
- Chart review: A research nurse conducts a chart review after patient's death. Cancer and cancer-related treatment data is obtained and documentation about pain management is recorded. From the time of study entry, all staff notes are reviewed to document pain assessment, calls to physician or other support personnel (including pharmacy calls), identified barriers to pain control, and treatment modifications (including medications to treat side effects).
After 20 patients, it was deemed not feasible to complete the study forms and to recruit adequately for the trial. The study was suspended.
Tipo di studio
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
Outpatient at the Alive Hospice in the State of Tennessee
- Diagnosed with carcinoma
- Pain requiring fixed-dose opioids
Caregiver for an Alive Hospice patient
- Any caregiver who is identified by the patient is eligible
PATIENT CHARACTERISTICS:
- Not pregnant or nursing
- Able to speak/comprehend English
- Lives within a 60-mile radius of Alive Hospice
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Supportive Care
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
To obtain determine the safety and feasibility of an opioid titration order sheet in the hospice setting.
Lasso di tempo: at 4 weeks
|
Pain assessments will be completed at baseline and daily for 4 weeks.
Survey instruments will be completed at the end of weeks 1, 2, and 3.
|
at 4 weeks
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Barbara A. Murphy, MD, Vanderbilt-Ingram Cancer Center
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- VICC SUPP 0822
- P30CA068485 (Sovvenzione/contratto NIH degli Stati Uniti)
- VU-VICC-SUPP-0822
- VU-VICC-IRB-IRB-080370
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Dolore
-
Cairo UniversityCompletatoSCOPO PAIN (VAS) a 24 ore dopo l'interventoEgitto
-
University of OklahomaThe Children's Hospital at OU Medical CenterCompletatoDolore addominale funzionale | Crisi falciforme | Pazienti seguiti dal Pain Team
-
King Abdulaziz UniversityReclutamentoDisturbi temporomandibolari (TMD) | Dolore dell'ATM | Arteterapia | TMJ - orale & amp; chirurgia maxillofaciale | Wilkes 1 e 2 | TMD Art Pain StudyArabia Saudita
Prove cliniche su revisione cartella clinica
-
General Practitioners Research InstituteAstraZenecaAttivo, non reclutante
-
University of RochesterRobert Wood Johnson FoundationCompletatoMalattia cardiovascolareStati Uniti
-
Schön Klinik Berchtesgadener LandCompletatoBroncopneumopatia cronica ostruttivaGermania
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityReclutamentoRadioterapia ridotta; Cancro alla testa e al colloCina
-
Visior Technologies Ltd.Completato
-
Equa HealthNational Institute of Mental Health (NIMH); Worcester Polytechnic InstituteReclutamentoDisagio psicologico | Abilità di consapevolezza | Soddisfazione dell'usabilitàStati Uniti
-
Schön Klinik Berchtesgadener LandCompletatoBroncopneumopatia cronica ostruttivaGermania
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke... e altri collaboratoriCompletatoAfasia cronicaStati Uniti
-
Soterix MedicalNYU Langone HealthCompletatoDepressione resistente al trattamento | Depressione unipolareStati Uniti
-
Matthew EagletonMassachusetts General HospitalIscrizione su invitoDissezione aortica | Dissezione dell'aorta ascendente | Aneurisma dell'aorta toracoaddominale | Aneurismi dell'aorta toracica | Dissezione, aneurisma | Aneurisma dell'aorta ascendente | Arco aortico; Aneurisma, dissezione | Aneurisma dell'arteria renale | Aneurisma dell'arteria mesenterica superioreStati Uniti